Kristina Wardelmann1,2,3,4, Michaela Rath1,4, José Pedro Castro5,6,7, Sabine Blümel1, Mareike Schell1,2,3, Robert Hauffe1,4, Fabian Schumacher8,9, Tanina Flore1,5, Katrin Ritter1, Andreas Wernitz10, Toru Hosoi11, Koichiro Ozawa12, Burkhard Kleuser8,9, Jürgen Weiß2,13, Annette Schürmann2,3, André Kleinridders1,2,4. 1. Junior Research Group Central Regulation of Metabolism, German Institute of Human Nutrition Potsdam-Rehbruecke, Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany. 2. German Center for Diabetes Research (DZD), Ingolstaedter Land Str. 1, 85764 Neuherberg, Germany. 3. Department of Experimental Diabetology, German Institute of Human Nutrition Potsdam-Rehbruecke, Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany. 4. Department of Molecular and Experimental Nutritional Medicine, Institute of Nutritional Science, University of Potsdam, 14558 Nuthetal, Germany. 5. Department of Molecular Toxicology, German Institute of Human Nutrition Potsdam-Rehbruecke, Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany. 6. Aging and Aneuploidy Laboratory, IBMC, Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135 Porto, Portugal. 7. Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal. 8. Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Str. 2+4, 14195 Berlin, Germany. 9. Department of Toxicology, University of Potsdam, Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany. 10. Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany. 11. Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Sanyo-Onoda City University, 1-1-1 Daigaku-dori, Sanyo Onoda, Yamaguchi 756-0884, Japan. 12. Department of Pharmacotherapy, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan. 13. German Diabetes Center (DDZ), Leibniz Center for Diabetes Research, Institute for Clinical Biochemistry and Pathobiochemistry, 40225 Duesseldorf, Germany.
Abstract
Mitochondria are critical for hypothalamic function and regulators of metabolism. Hypothalamic mitochondrial dysfunction with decreased mitochondrial chaperone expression is present in type 2 diabetes (T2D). Recently, we demonstrated that a dysregulated mitochondrial stress response (MSR) with reduced chaperone expression in the hypothalamus is an early event in obesity development due to insufficient insulin signaling. Although insulin activates this response and improves metabolism, the metabolic impact of one of its members, the mitochondrial chaperone heat shock protein 10 (Hsp10), is unknown. Thus, we hypothesized that a reduction of Hsp10 in hypothalamic neurons will impair mitochondrial function and impact brain insulin action. Therefore, we investigated the role of chaperone Hsp10 by introducing a lentiviral-mediated Hsp10 knockdown (KD) in the hypothalamic cell line CLU-183 and in the arcuate nucleus (ARC) of C57BL/6N male mice. We analyzed mitochondrial function and insulin signaling utilizing qPCR, Western blot, XF96 Analyzer, immunohistochemistry, and microscopy techniques. We show that Hsp10 expression is reduced in T2D mice brains and regulated by leptin in vitro. Hsp10 KD in hypothalamic cells induced mitochondrial dysfunction with altered fatty acid metabolism and increased mitochondria-specific oxidative stress resulting in neuronal insulin resistance. Consequently, the reduction of Hsp10 in the ARC of C57BL/6N mice caused hypothalamic insulin resistance with acute liver insulin resistance.
Mitochondria are critical for hypothalamic function and regulators of metabolism. pan class="Disease">Hypothalamic mitochondrial dysfunction with decreased mitochondrial chaperone expression is present in type 2 diabetes (T2D). Recently, we demonstrated that a dysregulated mitochondrial stress response (MSR) with reduced chaperone expression in the hypothalamus is an early event in obesity development due to insufficient insulin signaling. Although insulin activates this response and improves metabolism, the metabolic impact of one of its members, the mitochondrial chaperone heat shock protein 10 (Hsp10), is unknown. Thus, we hypothesized that a reduction of Hsp10 in hypothalamic neurons will impair mitochondrial function and impact brain insulin action. Therefore, we investigated the role of chaperone Hsp10 by introducing a lentiviral-mediated Hsp10 knockdown (KD) in the hypothalamic cell line CLU-183 and in the arcuate nucleus (ARC) of C57BL/6N male mice. We analyzed mitochondrial function and insulin signaling utilizing qPCR, Western blot, XF96 Analyzer, immunohistochemistry, and microscopy techniques. We show that Hsp10 expression is reduced in T2D mice brains and regulated by leptin in vitro. Hsp10 KD in hypothalamic cells induced mitochondrial dysfunction with altered fatty acid metabolism and increased mitochondria-specific oxidative stress resulting in neuronal insulin resistance. Consequently, the reduction of Hsp10 in the ARC of C57BL/6N mice caused hypothalamic insulin resistance with acute liver insulin resistance.
Authors: J C Brüning; D Gautam; D J Burks; J Gillette; M Schubert; P C Orban; R Klein; W Krone; D Müller-Wieland; C R Kahn Journal: Science Date: 2000-09-22 Impact factor: 47.728
Authors: Ulrich Stelzl; Uwe Worm; Maciej Lalowski; Christian Haenig; Felix H Brembeck; Heike Goehler; Martin Stroedicke; Martina Zenkner; Anke Schoenherr; Susanne Koeppen; Jan Timm; Sascha Mintzlaff; Claudia Abraham; Nicole Bock; Silvia Kietzmann; Astrid Goedde; Engin Toksöz; Anja Droege; Sylvia Krobitsch; Bernhard Korn; Walter Birchmeier; Hans Lehrach; Erich E Wanker Journal: Cell Date: 2005-09-23 Impact factor: 41.582
Authors: Anne Sigaard Bie; Cagla Cömert; Roman Körner; Thomas J Corydon; Johan Palmfeldt; Mark S Hipp; F Ulrich Hartl; Peter Bross Journal: Cell Stress Chaperones Date: 2020-02-14 Impact factor: 3.667
Authors: Katharina Timper; Lars Paeger; Carmen Sánchez-Lasheras; Luis Varela; Alexander Jais; Hendrik Nolte; Merly C Vogt; A Christine Hausen; Christian Heilinger; Nadine Evers; J Andrew Pospisilik; Josef M Penninger; Eric B Taylor; Tamas L Horvath; Peter Kloppenburg; Jens Claus Brüning Journal: Cell Rep Date: 2018-10-09 Impact factor: 9.423
Authors: José Pedro Castro; Kristina Wardelmann; Tilman Grune; André Kleinridders Journal: Front Endocrinol (Lausanne) Date: 2018-04-26 Impact factor: 5.555